Antitumor Activity and Safety of Tivozanib (AV-951) in a Phase II Randomized Discontinuation Trial in Patients With Renal Cell Carcinoma

标题
Antitumor Activity and Safety of Tivozanib (AV-951) in a Phase II Randomized Discontinuation Trial in Patients With Renal Cell Carcinoma
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 30, Issue 14, Pages 1678-1685
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2012-04-10
DOI
10.1200/jco.2011.35.3524

向作者/读者发起求助以获取更多资源

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started